-
Characterizing SARS-CoV-2-Specific Immunity in Convalescent Individuals
Source: HIV Vaccine Trial Network Statistical and Data Management Center (HVTN)Date Published: 5/13/2020Format: PDFAnnotation: The purpose of this study is to learn more about infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The information gained from the study will be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines and treatments by allowing researchers to determine the difference between the body's immune response to natural SARS-CoV-2 infection and immunization with a SARS-CoV-2 vaccine.
Questions Adapted From: CDC COVID-19 symptom list at the time of study deployment
Population: Adults recovered from SARS-CoV-2 infection
Language(s): English
Subject Case Report Form (CRS) https://disasterinfo.nlm.nih.gov/content/files/20200622_HVTN405HPTN1901_aCRF_v2.0.pdfType: Guideline/Assessment ToolAccess Notes: Free/Publicly Available
Available Formats: PDF
Contact Information: Jessica Andriesen; jandries@fredhutch.orgIncludes Research Tools: Yes.ID: 24211. From: Disaster Lit®a database of the U.S. National Library of Medicine.
of 1



